Torrent Pharma Data Theft Case: Ahmedabad Court Denies Bail to Man Accused of Rs 10 Crore Extortion Bid Written By Susmita Roy9 Aug 2026 11:15 AM ISTAhmedabad: An Ahmedabad Sessions Court has dismissed the bail application of Odisha resident K. Lokanath Subodh, who has been accused in a cybercrime...
India's GLP-1 Market Nears Rs 2,000 Crore as Semaglutide Boom Slows, Tirzepatide Regains Momentum Written By Susmita Roy21 Jun 2026 12:45 PM ISTNew Delhi: India's rapidly expanding GLP-1 agonist market is entering a new phase of maturity, with the explosive growth triggered by semaglutide...
Torrent Pharma Eyes India Launch of MASH Drug Resmetirom After Semaglutide Success Written By Parthika Patel26 May 2026 6:06 PM ISTNew Delhi: Torrent Pharmaceuticals is planning to introduce resmetirom, a new liver disease drug approved in the United States, in the Indian market...
Sakar Healthcare Signs Oncology Supply Pact with Zydus for GCC, Emerging Markets Written By sheeba farhat25 May 2026 12:30 PM ISTNew Delhi: Drug firm Sakar Healthcare on Thursday said it has signed an agreement with Zydus Lifesciences for the supply of oncology products across...
Torrent Pharma Q4 Profit Falls 27% to Rs 364 Cr Despite Strong India, US Growth Written By sheeba farhat25 May 2026 11:00 AM ISTNew Delhi: Torrent Pharmaceuticals Ltd on Friday reported a 27 per cent decline in profit after tax to Rs 364 crore in the fourth quarter ended March...
Generic Semaglutide Therapy Cost in India May Drop to Rs 500 a Month: Report Written By Parthika Patel15 May 2026 10:46 PM ISTNew Delhi: Prices of generic semaglutide, the popular weight-loss and anti-diabetes drug, are expected to decline sharply in India over the next six...
Torrent Emerges Early Leader in India's Generic Semaglutide Race with 38% Market Share: Report Written By Susmita Roy9 May 2026 5:23 PM ISTNew Delhi: Ahmedabad-based drug maker Torrent Pharma has emerged as the early frontrunner in India's fast-expanding generic semaglutide market,...
Torrent Pharma Gets Zero USFDA Observations for Bileshwarpura Oncology Facility Written By Parthika Patel11 April 2026 11:33 PM ISTNew Delhi: Torrent Pharmaceuticals Limited has successfully completed a USFDA inspection at its Bileshwarpura oncology manufacturing facility with...
UP Pharma Conclave 1.0: CM Yogi Promises Safety, Stability, Speed to Global Pharma Investors Written By sheeba farhat4 Feb 2026 8:16 PM ISTLucknow: Chief Minister Yogi Adityanath on Tuesday inaugurated the global congregation of investors and entrepreneurs 'Uttar Pradesh Pharma Conclave...
State Drug Alert: 141 Medicine Samples Including Mankind's Telmisartan Fail CDSCO Quality Tests in November Written By Susmita Roy23 Dec 2025 10:13 PM ISTNew Delhi: Reflecting continuing concerns over medicine quality in India's pharmaceutical supply chain, the Central Drugs Standard Control...
Torrent Pharma Slapped with Rs 41.33 Crore GST Penalty for Alleged Erroneous Export Refunds Written By Farhat Nasim28 Nov 2025 10:35 PM ISTNew Delhi: The Central GST authorities have passed an order against Torrent Pharma, imposing a penalty of Rs 41.33 crore, alleging that the company...
Torrent Pharma net profit rises 30 percent to Rs 591 crore in Q2 Written By Ruchika Sharma8 Nov 2025 4:30 PM ISTTorrent Pharmaceuticals has posted a robust 30 percent jump in its consolidated profit after tax (PAT) at Rs 591 crore for the September quarter,...
